Can we identify young people and adults who may benefit from methylphenidate, the most common medication for ADHD, from their initial response to a single test dose rather than after several weeks of daily treatment?
People with ADHD often wait months or years for treatment. Even after starting, finding a medication that suits them can involve weeks of testing tablets that might not work. If the first medicine fails, doctors have to try another, which can delay relief from symptoms. This study aims to see if doctors can predict whether methylphenidate (the most common ADHD medication) will help someone by checking their response to a single test dose. Participants aged 12 to 64 will take part in two testing days, comparing the medicine to a dummy pill using simple computer tasks and health checks. After testing, participants start their standard ADHD treatment with regular support from the research team over six months. The goal is to help future patients skip the frustrating trial-and-error process and find the right medication sooner.
At a glance
What is this study about?
Attention-deficit/hyperactivity disorder (ADHD) affects how people focus, manage energy, and control impulses. While medications like methylphenidate can make a huge positive difference, they do not work the same way for everyone. Currently, patients must take tablets daily for several weeks just to see if they help. If the medicine is not effective, they have to taper off and try a different one. This process can be slow, stressful, and disruptive to school, work, and family life.
Researchers at the University of Southampton want to find a faster way. They are testing whether a person's immediate reaction to a single dose of methylphenidate can reveal if it will be effective for them in the long run. By looking at quick changes in focus, memory, and heart rate after just one capsule, doctors hope to predict long-term success without weeks of waiting.
If this study succeeds, it could change how ADHD is treated across the NHS. Instead of relying on slow trial and error, doctors could quickly match people with the right treatment from day one, helping them manage their symptoms and get on with their lives much sooner.
Key takeaways
- Tests whether a single dose can predict if methylphenidate will work for your ADHD.
- Open to people aged 12 to 64 on specific NHS waiting lists in Hampshire or South London.
- Involves two initial test visits followed by six months of standard ADHD treatment.
- Provides regular check-ins from doctors and potential compensation for your time and travel.
- Completely voluntary with the freedom to leave the study at any point.
Who may be eligible?
This study is open to young people and adults aged 12 to 64 who have a confirmed diagnosis of ADHD. To take part, you must currently be on the waiting list to start ADHD treatment at either Hampshire and Isle of Wight Healthcare NHS Foundation Trust or South London and Maudsley NHS Foundation Trust. You must also be able to swallow small capsules and complete simple computer tasks.
You cannot join if you have taken methylphenidate in the past year, or if you are currently pregnant, planning a pregnancy, or breastfeeding. People taking other psychiatric medications are generally not able to join, although some sleep aids like melatonin are allowed.
Please note that you can only join if you are already on the waiting list at one of the two participating NHS trusts. The study cannot accept volunteers from other areas or through open website sign-ups.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am between 12 and 64 years old.
- I have an ADHD diagnosis and am waiting for treatment at Hampshire & Isle of Wight or South London & Maudsley NHS Trusts.
- I have not taken methylphenidate in the past 12 months.
- I can comfortably swallow small capsules.
- I am not pregnant, planning a pregnancy, or breastfeeding.
What does participation involve?
Taking part in the study lasts for about six months in total. At the start, you will attend two separate testing visits. On one day, you will take a single capsule of methylphenidate, and on the other day, you will take a placebo (a dummy pill containing no active medicine) so researchers can compare the effects. During these visits, you will answer questionnaires, complete attention tasks on a computer, and have your pulse and blood pressure checked.
After these two test days, you will begin your regular daily ADHD treatment with methylphenidate. Over the first two months, the study team will phone you regularly to see how you are feeling and help monitor your progress. You will then have follow-up reviews at two months and six months. You will receive £20 per visit for travel expenses, as well as £50 after the two-month check and £30 after the six-month check to thank you for your time.
Potential risks and benefits
Locations (3)
- Hampshire and Isle of Wight Healthcare NHS Foundation TrustCity onlySouthampton, England
- South London and Maudsley NHS Foundation TrustCity onlyBeckenham, England
- University of SouthamptonApproximateSouthampton, England
Common questions
What is a placebo?
A placebo is a dummy pill that looks just like the real medicine but contains no active ingredients. It helps researchers see which effects come from the medicine itself and which do not.
Will taking part speed up my ADHD treatment?
Yes, eligible participants are started on their standard ADHD treatment as part of the study, which may allow you to begin medication sooner than staying on the standard waiting list.
Can I join if I receive care from another NHS hospital?
No. Recruitment is strictly limited to people on the ADHD waiting lists at Hampshire and Isle of Wight Healthcare NHS Trust or South London and Maudsley NHS Trust.
What happens if the medication gives me unpleasant side effects?
An NHS doctor will monitor your health throughout the study. If you experience uncomfortable side effects, your doctor can adjust your dose or stop the medication safely.
Do I have to pay for anything during the study?
No. The medication and tests are free, you will receive up to £20 towards travel for your testing visits, and you will receive vouchers or payment for your time at the follow-up visits.
How to find out more
Valeria Parlatini
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.